Conference Recap Issue: 63rd American Society of Hematology Meeting & Exposition
ASH 2021 Recap: Real-World Evidence
A presentation at the 63rd American Society of Hematology (ASH) annual meeting explored the collection of real-world data.
ASH 2021 Recap: Multiple Myeloma
The 63rd American Society of Hematology (ASH) Annual Meeting and Exposition featured leading experts who discussed research on multiple myeloma.
ASH 2021 Recap: CAR T-Cell Therapy
Ongoing and new developments in chimeric antigen receptor (CAR) T-cell therapies were covered at the 63rd American Society of Hematology (ASH) annual meeting.
ASH 2021 Recap: Leukemia & Lymphoma
Clinical trial results in the leukemia and lymphoma space were covered at the 63rd American Society of Hematology (ASH) annual meeting.
ASH 2021 Recap: Disparities in Care
Disparities and inequities in care were topics of interest at the 63rd American Society of Hematology (ASH) annual meeting.
ASH 2021 Recap: Research From Our Partners
Featuring abstracts from the Association of Community Cancer Centers, US Oncology, City of Hope, and Florida Cancer Specialists & Research Institute.
SGLT-2s, GLP-1s, Finerenone Have Unique Benefits in CKD, Diabetes: Meta-Analysis
Adding Venetoclax to Decitabine-Cedazuridine Improves Response in MDS Subgroups
Clinical, Real-World Data Support Importance of Tocilizumab for RA
5 Challenges the Affordable Care Act Overcame in the Last 15 Years
